Join our Stock Market News Group at GetPaidIndia on Telegram and WhatsApp.

This website is purely ACADEMIC in nature and NOT a stock market recommendation service or a tip provider. No live data or feeds are provided and all information is historic only. Information is provided for ease of understanding for the purpose of learning. Accuracy of definitions etc is not mantained. I am not a SEBI or IRDA registered.

Main Page



From GetPaidIndia.com
Revision as of 22:48, 13 September 2017 by Webgeek (Talk | contribs)

Jump to:navigation, search

Welcome to GetPaidIndia.com

This is an academic website to learn about equities in general. This website does not make any suggestions or recommendations but only track information that is already available in public domain.

SuperTrend and PSAR turning Buy Recently

SuperTrend and PSAR turning Buy Shortly

News Updates

  • Aditya Birla Capital Limited (540691): Trading Members of the Exchange are hereby informed that effective from September 01, 2017, the equity shares of Aditya Birla Capital Ltd (Scrip Code: 540691) are listed and admitted to dealings on the Exchange in the list of 'T' Group Securities. For further details please refer to the notice no 20170830-13 dated August 30, 2017.
  • Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated Jun 14, 2017, titled "SPARC Announces Top-line Results of Pivotal Peak Inspiratory Flow (PIF) study and Low Dose Pharmacokinetic (PK) Study for Salmeterol Fluticasone Dry Powder Inhaler (SPARC DPI)".
  • Lupin receives FDA approval for generic Roxicodone Tablets
  • Bharat Financial Inclusion Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 07, 2017.

Quarterly Results and Board Meetings

Board Meetings / Quarterly Results

Index Watch

Stock Collections

Analysts / Brokerage Firms